Telescope Innovations Corp. engages in the development and manufacture of chemical technologies for pharmaceuticals and chemical industries. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2021-09-27. The firm is developing scalable manufacturing processes and tools for the pharmaceutical and chemical industries. The firm builds and deploys new enabling technologies, including flexible robotic platforms and artificial intelligence software that improves experimental throughput, efficiency, and data quality. Its core technology also enables the discovery of novel molecules of therapeutics. Its suite of analytical and automation technologies, including the Direct Inject Liquid Chromatography (DILC) platform for quantitative, online reaction monitoring. DILC is a hardware and software ecosystem that enables direct sampling and analysis of chemical reactions. DILC enables unattended sample capture, quenching, dilution, and analysis using a variety of industry standard CDS platforms, including Agilent OpenLab, Agilent ChemStation, Waters Empower 3, and Shimadzu LabSolutions.
Follow-Up Questions
Who is the CEO of Telescope Innovations Corp?
Prof. Jason Hein is the Chief Executive Officer of Telescope Innovations Corp, joining the firm since 2021.
What is the price performance of TELIF stock?
The current price of TELIF is $0.2358, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Telescope Innovations Corp?
Telescope Innovations Corp belongs to N/A industry and the sector is N/A
What is Telescope Innovations Corp market cap?
Telescope Innovations Corp's current market cap is $12.6M
